Browsing by Subject "hypertension, cost effectiveness, cost effectiveness analysis (CEA), amlodipine, captopril."
Now showing items 1-1 of 1
-
COST EFFECTIVENESS ANALYSIS PENGGUNAAN CAPTOPRIL DAN AMLODIPIN PADA PASIEN HIPERTENSI PRIMER DI PUSKESMAS GONDOKUSUMAN I
(FAKULTAS KEDOKTERAN DAN ILMU KESEHATAN UNIVERSITAS MUHAMMADIYAH YOGYAKARTA, 2019-05-20)Hypertension is often called the silent killer because hypertensive sufferers in general do not experience complaints and only feels complaints after being complicated. The prevalence of hypertension in Indonesia is based ...